Northeast Financial Consultants Inc Vertex Pharmaceuticals Inc Transaction History

Northeast Financial Consultants Inc

$2.25 Billion
Q3 2024

A detailed history of Northeast Financial Consultants Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 5,974 shares of VRTX stock, worth $2.44 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

5,974

Previous 5,962 0.2%

Holding current value

$2.44 Million

Previous $2.79 Million 0.57%

% of portfolio

0.12%

Previous 0.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$460.0 - $505.78 $5,520 - $6,069	12 Added 0.2%	5,974 $2.78 Million
Q2 2024 Aug 15, 2024	BUY	$392.81 - $485.53 $9,820 - $12,138	25 Added 0.42%	5,962 $2.79 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $27,392 - $29,359	81 Added 1.38%	5,937 $2.06 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $75,622 - $86,267	-267 Reduced 4.36%	5,856 $1.85 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $60,009 - $67,510	210 Added 3.55%	6,123 $1.77 Million
Q3 2022 Nov 15, 2022	SELL	$273.83 - $305.53 $193,871 - $216,315	-708 Reduced 10.69%	5,913 $1.71 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $594,448 - $740,151	-2,530 Reduced 27.65%	6,621 $1.87 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $106,060 - $125,004	479 Added 5.52%	9,151 $2.39 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $82,309 - $103,904	-465 Reduced 5.09%	8,672 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $12,334 - $13,803	68 Added 0.75%	9,137 $1.66 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $9,936 - $11,718	53 Added 0.59%	9,069 $1.83 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $946,495 - $1.1 Million	4,572 Added 102.88%	9,016 $1.94 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $52,787 - $70,402	-255 Reduced 5.43%	4,444 $1.05 Million
Q3 2020 Oct 29, 2020	BUY	$255.65 - $303.1 $1,022 - $1,212	4 Added 0.09%	4,699 $1.28 Million
Q2 2020 Jul 30, 2020	BUY	$225.48 - $295.8 $146,336 - $191,974	649 Added 16.04%	4,695 $1.36 Million
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $14,982 - $18,585	75 Added 1.89%	4,046 $963,000
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $25,006 - $33,586	-150 Reduced 3.64%	3,971 $869,000
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $674,731 - $802,358	4,121 New	4,121 $758,000
Q3 2018 Nov 08, 2018	SELL	$167.73 - $192.74 $4.02 Million - $4.62 Million	-23,971 Closed	0 $0
Q1 2018 Apr 19, 2018	SELL	$151.6 - $177.13 $5,912 - $6,908	-39 Reduced 0.16%	23,971 $3.91 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $5,353 - $6,066	39 Added 0.16%	24,010 $3.6 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $3.55 Million - $3.89 Million	23,971	23,971 $3.65 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Account

Northeast Financial Consultants Inc Vertex Pharmaceuticals Inc Transaction History